Publications by authors named "David P Steensma"

100Publications

Roald Dahl: Children's Book Author, Medical Device Inventor, Myelodysplastic Syndrome Patient, and Philanthropist.

Mayo Clin Proc 2020 Nov;95(11):e119-e120

Division of Hematology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2020.09.025DOI Listing
November 2020

Fernando Figueira: Brazilian Public Health Champion.

Mayo Clin Proc 2020 09;95(9):e97-e98

Division of Hematology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2020.07.011DOI Listing
September 2020

Loss of 5q in myeloid malignancies - A gain in understanding of biological and clinical consequences.

Blood Rev 2020 Jul 23:100735. Epub 2020 Jul 23.

Division of Hematological Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute; Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2020.100735DOI Listing
July 2020

What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinics.

Blood 2020 Oct;136(14):1623-1631

Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019004291DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530645PMC
October 2020

James Allison and Cancer Immunotherapy.

Mayo Clin Proc 2020 07;95(7):e75-e76

Mayo Clinic, Rochester, MN. Electronic address: https://twitter.com/RobertK68033234.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2020.05.020DOI Listing
July 2020

The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor.

JAMA Cardiol 2020 May 27. Epub 2020 May 27.

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2020.1271DOI Listing
May 2020

Razi: Critical Thinker, and Pioneer of Infectious Disease and Ophthalmology.

Mayo Clin Proc 2020 05;95(5):e53-e54

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2020.03.014DOI Listing
May 2020

Patients with haematological malignancies should not have to choose between transfusions and hospice care.

Lancet Haematol 2020 May;7(5):e418-e424

Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(20)30042-9DOI Listing
May 2020

Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities.

Clin Lymphoma Myeloma Leuk 2020 Sep 20;20(9):e597-e605. Epub 2020 Mar 20.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.03.005DOI Listing
September 2020

Does clonal hematopoiesis explain unexplained anemia?

Authors:
David P Steensma

Blood 2020 04;135(14):1080-1082

Dana-Farber Cancer Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2020005293DOI Listing
April 2020

Recognizing "diagnostic futility" - stopping earlier to protect patients.

Am J Hematol 2020 06 27;95(6):580-582. Epub 2020 Mar 27.

Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25786DOI Listing
June 2020

Young and Restless: Expansion of Donor-Origin Mutant HSCs after Transplantation.

Authors:
David P Steensma

Cell Stem Cell 2020 03;26(3):305-306

Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stem.2020.01.022DOI Listing
March 2020

Ibn Sina (Avicenna): The "Prince of Physicians".

Mayo Clin Proc 2020 03;95(3):e31-e32

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2020.01.023DOI Listing
March 2020

Bone marrow niches in haematological malignancies.

Nat Rev Cancer 2020 05 28;20(5):285-298. Epub 2020 Feb 28.

Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Medicine, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41568-020-0245-2DOI Listing
May 2020

Myelodysplastic Syndromes.

Authors:
David P Steensma

Hematol Oncol Clin North Am 2020 Apr 6;34(2):xv-xvi. Epub 2020 Jan 6.

Division of Hematological Malignancies, Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2019.12.001DOI Listing
April 2020

Targeting Aberrant Splicing in Myelodysplastic Syndromes: Biologic Rationale and Clinical Opportunity.

Hematol Oncol Clin North Am 2020 Apr 11;34(2):379-391. Epub 2019 Dec 11.

Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2019.10.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045909PMC
April 2020

Alexandre Yersin: Discoverer of the Plague Bacillus.

Mayo Clin Proc 2020 01;95(1):e7-e8

Division of Hematology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2019.11.006DOI Listing
January 2020

Clonal hematopoiesis as a model for premalignant changes during aging.

Exp Hematol 2020 03 12;83:48-56. Epub 2019 Dec 12.

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2019.12.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103509PMC
March 2020

Does early diagnosis and treatment of myelodysplastic syndromes make a difference?

Authors:
David P Steensma

Best Pract Res Clin Haematol 2019 12 18;32(4):101099. Epub 2019 Oct 18.

Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.101099DOI Listing
December 2019

The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS).

Authors:
David P Steensma

Curr Hematol Malig Rep 2019 12;14(6):536-542

Dana-Farber Cancer Institute, Center for Prevention of Progression of Hematological Malignancies, Edward P. Evans Center for Myelodysplastic Syndromes, Harvard Medical School, 450 Brookline Ave., Dana 2037, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-019-00547-3DOI Listing
December 2019

Luke Fildes and The Doctor.

Mayo Clin Proc 2019 11;94(11):e131-e132

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2019.09.016DOI Listing
November 2019

Baron Aarnoud van Heemstra, Humanitarian Governor of Suriname and Grandfather of Audrey Hepburn.

Mayo Clin Proc 2019 09;94(9):e111-e112

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2019.07.015DOI Listing
September 2019

Albert Schweitzer: Humanitarian With a "Reverence for Life".

Mayo Clin Proc 2019 07;94(7):e91-e92

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2019.05.009DOI Listing
July 2019

Andreas Vesalius and De Fabrica.

Mayo Clin Proc 2019 05;94(5):e67-e68

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2019.03.018DOI Listing
May 2019

John Shaw Billings: Civil War Surgeon, Medical Librarian, Founder of Index Medicus, and First Director of the New York Public Library.

Mayo Clin Proc 2019 03;94(3):e45-e46

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2019.01.023DOI Listing
March 2019

Rethinking clinical trial endpoints in myelodysplastic syndromes.

Leukemia 2019 03 30;33(3):570-575. Epub 2019 Jan 30.

Leukemia Programs, Cleveland Clinic Taussig Cancer Institute and Dana-Farber Cancer Institute, Cleveland, OH, and Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0367-7DOI Listing
March 2019

Georges de Bellio (1826-1894): Doctor, Friend, and Patron of the Impressionist Painters.

Mayo Clin Proc 2019 01;94(1):e7

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2018.11.009DOI Listing
January 2019

Clinical consequences of clonal hematopoiesis of indeterminate potential.

Authors:
David P Steensma

Hematology Am Soc Hematol Educ Program 2018 11;2018(1):264-269

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2018.1.264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245996PMC
November 2018

Clinical consequences of clonal hematopoiesis of indeterminate potential.

Authors:
David P Steensma

Blood Adv 2018 11;2(22):3404-3410

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://www.bloodadvances.org/lookup/doi/10.1182/bloodadvance
Publisher Site
http://dx.doi.org/10.1182/bloodadvances.2018020222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258914PMC
November 2018

Herman Boerhaave - Master Clinician and Humanist.

Mayo Clin Proc 2018 11;93(11):e119-e120

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2018.09.014DOI Listing
November 2018

Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions.

Cancer 2018 12 5;124(24):4601-4609. Epub 2018 Oct 5.

Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31769
Publisher Site
http://dx.doi.org/10.1002/cncr.31769DOI Listing
December 2018

An RNA bestiary in splicing-mutant MDS.

Authors:
David P Steensma

Blood 2018 09;132(12):1217-1219

Dana-Farber Cancer Institute.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2018-07
Publisher Site
http://dx.doi.org/10.1182/blood-2018-07-859942DOI Listing
September 2018

How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes.

Authors:
David P Steensma

Blood 2018 10 5;132(16):1657-1663. Epub 2018 Sep 5.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-06-860882DOI Listing
October 2018

Clinical Implications of Clonal Hematopoiesis.

Authors:
David P Steensma

Mayo Clin Proc 2018 08 4;93(8):1122-1130. Epub 2018 Jul 4.

Adult Leukemia Program, Division of Hematological Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2018.04.002DOI Listing
August 2018

Uncoupling of CD71 shedding with mitochondrial clearance in reticulocytes in a subset of myelodysplastic syndromes.

Leukemia 2019 01 26;33(1):217-229. Epub 2018 Jul 26.

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0204-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432991PMC
January 2019

Impact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes.

Am J Hematol 2018 09 28;93(9):1119-1126. Epub 2018 Aug 28.

Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25166DOI Listing
September 2018

Henry David Thoreau's Final Journey: Minnesota.

Mayo Clin Proc 2018 07;93(7):e75-e76

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.07.021DOI Listing
July 2018

Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis.

Clin Lymphoma Myeloma Leuk 2018 08 26;18(8):528-532. Epub 2018 May 26.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.05.016DOI Listing
August 2018

Myelodysplastic syndromes current treatment algorithm 2018.

Authors:
David P Steensma

Blood Cancer J 2018 05 24;8(5):47. Epub 2018 May 24.

Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0085-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967332PMC
May 2018

Fertility preservation in women with marrow failure syndromes prior to allogeneic stem cell transplantation.

Am J Hematol 2018 May 13. Epub 2018 May 13.

Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25130DOI Listing
May 2018

Recent advances in the cellular and molecular understanding of myelodysplastic syndromes: implications for new therapeutic approaches.

Clin Adv Hematol Oncol 2018 Jan;16(1):56-66

Harvard Medical School, and Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629038PMC
January 2018

Jöns Jacob Berzelius - A Father of Chemistry.

Mayo Clin Proc 2018 05;93(5):e53-e54

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.07.020DOI Listing
May 2018

New Insights from Studies of Clonal Hematopoiesis.

Clin Cancer Res 2018 10 27;24(19):4633-4642. Epub 2018 Apr 27.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-17-3044DOI Listing
October 2018

Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid Leukemia.

N Engl J Med 2018 03;378(13):1244-1245

From the Dana-Farber Cancer Institute and Harvard Medical School - both in Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1802610DOI Listing
March 2018

Christian Albert Theodor Billroth: Founder of Abdominal Surgery.

Mayo Clin Proc 2018 03;93(3):e29-e30

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.06.026DOI Listing
March 2018

Prognosis in myelodysplastic syndromes: The attractions and limitations of simplicity.

Authors:
David P Steensma

Am J Hematol 2018 05 26;93(5):605-606. Epub 2018 Feb 26.

Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25068DOI Listing
May 2018

The bone-marrow niche in MDS and MGUS: implications for AML and MM.

Nat Rev Clin Oncol 2018 04 9;15(4):219-233. Epub 2018 Jan 9.

Division of Hematological Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.197DOI Listing
April 2018

Álvaro Alvim-Radiologist and Brazilian "Martyr to Science".

Mayo Clin Proc 2018 01;93(1):e7

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.06.025DOI Listing
January 2018

The Raven.

Authors:
David P Steensma

J Clin Oncol 2018 02 13;36(5):512-513. Epub 2017 Dec 13.

David P. Steensma, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.3458DOI Listing
February 2018

The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromes.

Authors:
David P Steensma

Best Pract Res Clin Haematol 2017 12 22;30(4):295-300. Epub 2017 Sep 22.

Dana-Farber Cancer Institute, Boston, MA, 02115, USA; Harvard Medical School, Boston, MA, 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2017.09.009DOI Listing
December 2017

Thalassemia and Thomas Benton Cooley.

Mayo Clin Proc 2017 11 1;92(11):e161-e162. Epub 2017 Nov 1.

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.06.024DOI Listing
November 2017

Charles Fletcher, The Centaur Company, and Proprietary Medicine Revenue Stamps.

Mayo Clin Proc 2017 09;92(9):e127-e128

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.06.021DOI Listing
September 2017

A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials.

Cancer 2017 Oct 31;123(19):3662-3672. Epub 2017 Jul 31.

Department of Hematology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30903DOI Listing
October 2017

Adolf Lorenz - The Bloodless Surgeon of Vienna.

Mayo Clin Proc 2017 07;92(7):e105-e106

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.02.025DOI Listing
July 2017

Antonius Mathijsen and Plaster Casts.

Mayo Clin Proc 2017 05;92(5):e83

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.01.028DOI Listing
May 2017

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

J Clin Oncol 2017 May 28;35(14):1591-1597. Epub 2017 Mar 28.

Sophie Park, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, Université Grenoble Alpes, Grenoble; Jean-François Hamel and Sylvain Thépot, CHU d'Angers; Sylvain Thépot, Université d'Angers, Institut National de la Santé et de la Recherche Médicale, Unité 1232, and LabEx IGO, Angers; Andrea Toma, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris-Est Créteil; Rosa Sapena and Pierre Fenaux, CHU Saint Louis, AP-HP, Université Paris X; François Dreyfus, CHU Cochin, AP-HP, Université Paris V, Paris; Charikleia Kelaidi, CHU Avicenne, Avicenne; Odile Beyne-Rauzy, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Agnès Guerci-Bresler, CHU Nancy, Nancy; Dominique Bordessoule, CHU Dupuytren, Limoges; Pascale Cony-Makhoul, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy; Stéphane Cheze, CHU de Caen, Caen; Eric Wattel, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon; Christian Rose, Université Catholique de Lille, Lille; Norbert Vey, Institut Paoli-Calmettes Marseille, Marseille, France; Maria Diez Campelo, Hospital Universitario de Salamanca, Salamanca; Teresa Bernal, Hospital Central de Asturias, Oviedo; Fernando Ramos, Hospital de León, León; Marisa Calabuig, Hospital Clínico de Valencia; Guillermo F. Sanz, Hospital Universitario y Politecnico La Fe, Valencia, Spain; Valeria Santini and Alessandro Sanna, Azienda Ospedaliero Universitaria (AOU) Careggi and University of Florence, Florence; Enrico Balleari, Istituto di Ricovero e Cura a Carattere Scientifico AOU San Martino di Genova, Genova; Daniela Gioia, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria; Dario Ferrero, Università degli Studi di Torino; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Torino; Giovanni Cametti, Ospedale Maggiore di Chieri, Chieri; Fabrizio Pane, Università Federico II, Napoli, Italy; Mikkael A. Sekeres and Jaime Fensterl, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Rami Komrokji, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David P. Steensma, Dana-Farber Cancer Institute, Boston, MA; Gail J. Roboz, Weill Medical College of Cornell University, New York, NY; Jennifer Kaivers and Ulrich Germing, University of Düsseldorf, Düsseldorf; Katharina Götze and Catharina Müller-Thomas, Universität München, München, Germany; and Ioannis Kotsianidis, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3271DOI Listing
May 2017

The origin and evolution of the term "clone".

Authors:
David P Steensma

Leuk Res 2017 06 4;57:97-101. Epub 2017 Mar 4.

Dana-Farber Cancer Institute and Harvard Medical School, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.03.004DOI Listing
June 2017